Tech Company Financing Transactions

Purigen Biosystems Funding Round

Agilent Technologies, 5AM Ventures and Cota Capital participated in a $26.4 million Series B funding round for Purigen Biosystems. The round was recorded on 6/13/2019.

Transaction Overview

Company Name
Purigen Biosystems
Announced On
6/13/2019
Transaction Type
Venture Equity
Amount
$26,400,000
Round
Series B
Investors

Agilent Technologies (Lead Investor) (Kevin Corcoran)

5AM Ventures (Andy Schwab)

Cota Capital (Bobby Yazdani)

Roche Venture Fund (Tracy Saxton)

Proceeds Purpose
Purigen will use the proceeds from the financing to expand its scientific and commercial operations, accelerate the launch of its core isotachophoresis (ITP) sample preparation platform, and support the development of new features for future applications.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5700 Stoneridge Dr. 100
Pleasanton, CA 94588
USA
Phone
(925) 264-1364
Website
www.purigenbio.com
Email Address
[email protected]
Overview
Purigen Biosystems is redefining nucleic acid sample prep by providing an innovative platform based on the remarkably efficient isotachophoresis technology invented in the lab of Stanford University professor Juan Santiago.
Profile
Purigen Biosystems LinkedIn Company Profile
Social Media
Purigen Biosystems Company Twitter Account
Company News
Purigen Biosystems News
Facebook
Purigen Biosystems on Facebook
YouTube
Purigen Biosystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Barney Saunders
  Barney Saunders LinkedIn Profile  Barney Saunders Twitter Account  Barney Saunders News  Barney Saunders on Facebook
Chief Financial Officer
Steve Reichenbach
  Steve Reichenbach LinkedIn Profile  Steve Reichenbach Twitter Account  Steve Reichenbach News  Steve Reichenbach on Facebook
Chief Scientific Officer
Klint Rose
  Klint Rose LinkedIn Profile  Klint Rose Twitter Account  Klint Rose News  Klint Rose on Facebook
Co-Founder
Juan Santiago
  Juan Santiago LinkedIn Profile  Juan Santiago Twitter Account  Juan Santiago News  Juan Santiago on Facebook
VP - Operations
Pam Delucchi
  Pam Delucchi LinkedIn Profile  Pam Delucchi Twitter Account  Pam Delucchi News  Pam Delucchi on Facebook
VP - Sales
Chris Grimley
  Chris Grimley LinkedIn Profile  Chris Grimley Twitter Account  Chris Grimley News  Chris Grimley on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/13/2019: Mythic venture capital transaction
Next: 6/13/2019: Hi Marley venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record every notable VC transaction. All VC database entries reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.